Neuberg Diagnostics secures ₹940 crore from Kotak fund
The diagnostics network will use the financing to acquire regional businesses and expand services.
Kotak Strategic Situations India Fund II announced a ₹940 crore investment in Neuberg Diagnostics on 10 January 2025. The fund is managed by Kotak Alternate Asset Managers.
The capital will support acquisitions and the integration of regional diagnostic businesses, alongside expansion in personalised medicine and integrated diagnostics. Neuberg operates a laboratory network offering routine tests and specialised services including genomics.
Octus’s transaction research identifies the financing as optionally convertible debentures. The investment announcement also described plans to prepare the business for an initial public offering.
Use of funds
Acquisitions and integration of regional diagnostics businesses
Personalized medicine and integrated diagnostics